Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,101,361
+$54,413 QoQ
Shares Held
16,149
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#1,753
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BEACON FINANCIAL GROUP holds $17,924,673 across 8 Drug Manufacturers - General names. JNJ ranks #1 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
16,149 | $4,101,361 | |
| 2 | AMGN |
Amgen Inc
|
8,964 | $3,246,043 | |
| 3 | NVS |
Novartis AG
|
20,231 | $3,170,602 | |
| 4 | ABBV |
AbbVie Inc.
|
10,847 | $2,729,539 | |
| 5 | PFE |
Pfizer Inc
|
94,815 | $2,283,145 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,047 | $905,539 | |
| 7 | LLY |
ELI LILLY & Co
|
740 | $887,578 | |
| 8 | SNY |
Sanofi
|
14,085 | $600,866 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,101,361 | 16,149 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,046,948 | 16,556 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,478,208 | 16,807 | Shares | Sole | 2026-04-01 | |
| 2025-09-30 | $3,262,279 | 17,594 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $2,752,096 | 18,017 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,328,740 | 20,072 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,981,341 | 20,615 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,508,761 | 21,651 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,241,682 | 22,179 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,608,472 | 22,811 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,668,029 | 23,402 | Shares | Sole | 2024-02-23 | |
| 2023-09-30 | $3,785,192 | 24,303 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $4,088,509 | 24,701 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,816,410 | 24,622 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $4,489,029 | 25,412 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $4,159,799 | 25,464 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,605,319 | 25,944 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,410,014 | 24,883 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $4,266,999 | 24,943 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $4,154,103 | 25,722 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $4,219,485 | 25,613 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $4,475,414 | 27,231 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $4,285,614 | 27,231 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $4,110,725 | 27,611 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,907,263 | 27,784 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $6,409,503 | 48,879 | Shares | Sole | 2020-06-29 | |
| No filing history on record for this holder in this stock. | ||||||